相关实验视频
Updated: Jun 30, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
关于治疗和随访原发性阿尔多斯特主义的实际共识:一个多学科的共识文件
Marta Araujo-Castro1, Jorge Gabriel Ruiz-Sánchez2, Paola Parra Ramírez3
1Endocrinology & Nutrition Department. Hospital Universitario Ramón y Cajal. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), University of Alcalá, Madrid, Spain. marta.araujo@salud.madrid.org.
Endocrine
|March 20, 2024
概括
原发性阿尔多斯特隆症 (PA) 是二次高血压的常见原因,具有更高的心脏代谢风险. 这种共识为PA提供了专家建议.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 放射学 放射学是一门学科.
- 病理学 病理学 病理学
- 外科手术 手术手术
背景情况:
- 主要的阿尔多斯特主义 (PA) 是二次高血压的主要原因.
- 与基本高血压相比,PA与心脏代谢风险的增加有关.
研究的目的:
- 为管理原发性阿尔多斯特隆症制定实用临床建议.
- 涵盖手术和医疗治疗,诊断研究和后续协议.
- 针对特殊患者群体,包括老年人,孕妇和慢性病患者.
主要方法:
- 使用了名义上的群体共识方法.
- 从多个西班牙医学协会收集了专家意见.
- 多学科的观点为这些建议提供了信息.
主要成果:
- 为PA诊断和管理制定了全面的指导方针.
- 概述了治疗和随访的具体策略.
- 考虑独特的临床情景被整合.
结论:
- 这种共识为最佳的原发性阿尔多斯顿症护理提供了一个多学科的框架.
- 这些建议旨在改善患者的治疗结果,并减少心脏代谢风险.
- 为手术,医疗和随访策略提出了标准化的方法.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
428
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Antihypertensive Drugs: Direct Renin Inhibitors
621
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
621
Hormonal Regulation
33.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.1K
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics
534
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
534
Antihypertensive Drugs: Angiotensin II Receptor Blockers
726
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
726

